U.S. Biotech Stock News

In recent months, American International Group (AIG) lifted its annualized dividend by 14.3% year over year, taking its yield above the finance industry average and pairing this with guidance for stronger earnings in 2026. This combination of robust dividend growth and upbeat earnings expectations signals management’s confidence in AIG’s cash generation and balance-sheet flexibility. Against this backdrop of faster dividend growth, we’ll examine how the latest update could reshape AIG’s...

FedEx files new shelf registration after strong quarter FedEx (FDX) has filed an omnibus shelf registration for common stock and debt securities shortly after reporting better than expected fourth quarter results, putting fresh attention on the company’s future funding and capital plans. See our latest analysis for FedEx. FedEx’s recent shelf registration comes after a period where short term share price momentum has cooled, with the stock down 18.8% over 90 days. However, the 1 year total...

Bath & Body Works, Inc. has already entered Brazil with its first store and digital destination, tailoring assortments like fruity and tropical fragrances and the Brazil-inspired Viva collection to local consumer preferences. This move adds Brazil to a network of more than 550 international locations across over 45 countries, highlighting how its franchise-partner model is being used to refine assortments using regional consumer insight. Next, we’ll examine how this Brazil entry,...

First Industrial Realty Trust stock has delivered a 42.3% return over the past three years, and the latest checks point to a company that now looks closer to fairly priced. The Discounted Cash Flow (DCF) intrinsic value estimate is sitting near the current share price, while earnings based multiples still screen as supportive. Over the last 3 years, First Industrial Realty Trust has returned 42.3%, which puts more pressure on investors to judge whether the current level offers enough...

CSX (CSX) is back in focus after releasing second quarter 2026 results, updating its full year guidance and detailing recent buybacks and dividend plans, giving investors fresh information to assess the stock. See our latest analysis for CSX. CSX shares have been climbing, with a 30 day share price return of 11.69% and a year to date share price return of 46.76%. The 1 year total shareholder return of 50.96% points to strong momentum building around the stock. If the recent move in CSX has...

AGCO stock has gained 14.5% year to date, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a discount to what the underlying business may justify. Year to date, AGCO is up 14.5%, which puts recent returns into positive territory while still leaving room for a potential valuation gap. Attention on agricultural machinery components and precision farming, including AGCO's involvement in brand agnostic precision...

Kestra Medical Technologies (NasdaqGS:KMTS) arranged a $200 million non-dilutive five year term loan facility. The financing includes new lending partnerships with BPCR Limited Partnership and BioPharma Credit Investments V. The company refinanced and retired existing debt as part of the transaction, while maintaining a solid cash position. Kestra Medical Technologies enters this financing with a mixed recent share price record. The stock is up 27.3% over the past year, while down 13.8%...

State Street Corporation has reported past second-quarter 2026 results showing net income of US$1.08 billion and diluted earnings per share from continuing operations of US$3.65, alongside declaring higher common and preferred dividends and confirming completion of a US$2.90 billion buyback that retired 10.25% of its shares since early 2024. The combination of stronger earnings, a richer cash return profile and a fully executed multi‑year repurchase program underscores how management is...

Resideo Technologies (REZI) has drawn fresh attention after recent coverage highlighted its history of topping earnings estimates, with analysts increasingly expecting another potential beat that could keep investor sentiment focused on upcoming results. See our latest analysis for Resideo Technologies. Recent optimism around Resideo Technologies’ earnings record comes after a mixed price pattern, with the share price up 11.56% over the past month but down 14.72% over the past quarter, while...

Knowles (KN) drew investor attention after reporting fiscal Q2 2026 results above its prior guidance and lifting full year revenue and earnings forecasts, supported by strength in Precision Devices and MedTech & Specialty Audio. See our latest analysis for Knowles. Despite the post earnings pullback, with a 1 day share price return down 3.2%, Knowles has strong momentum in the background, with a year to date share price return of 71.2% and a 1 year total shareholder return of 84.3%. If strong...

Hasbro, Inc. reported second-quarter 2026 sales of US$1,139.6 million and net income of US$160.9 million, reversing a very large prior-year loss, while also affirming a quarterly dividend of US$0.70 per share. Alongside these stronger results, Hasbro highlighted fresh content and collectibles across franchises like Star Wars, My Little Pony, Ghostbusters, and KPop Demon Hunters, underscoring how its entertainment pipeline and licensed IP continue to underpin its toy and gaming...

Fidelity National Financial recently reported its second quarter 2026 results and held an earnings conference call, updating the market on performance across its Title, F&G, and Corporate and Other segments. This earnings update offers investors a fresh read on how the company’s diversified title and insurance operations are balancing costs, digital investment, and segment mix. Now we’ll explore how the latest quarterly earnings call reframes Fidelity National Financial’s investment...

Luckin Coffee stock has returned about 162.7% over the past five years, yet its broader valuation checks still indicate the shares screen as cheap relative to fundamentals, which puts recent weakness this year in a different light for investors trying to judge value today. Over five years, a 162.7% return suggests Luckin Coffee has already rewarded patient shareholders, so the key issue now is whether the current price still offers an attractive entry point for new capital. The push into New...

Qorvo stock has been roughly flat over the past year but has declined sharply over five years, and the latest valuation work suggests the current share price sits close to its estimated intrinsic value rather than at a clear discount or premium. Qorvo shareholders have seen the stock decline about 54% over the past 5 years, which puts the recent share price in the context of a long period of weak returns. The new distribution agreement with Rochester Electronics can support long term demand...

Earlier in July 2026, Erasca reported updated preliminary Phase 1 data showing generally well-tolerated monotherapy and promising combination potential for its investigational pan-RAS molecular glue ERAS-0015 in RAS-mutant solid tumors, while also raising approximately US$550.00 million through a follow-on common stock offering and filing an omnibus shelf registration. At the same time, multiple securities class actions and investigations emerged alleging patent infringement, trade secret...

Concentra Group Holdings Parent (CON) is in focus after announcing a new medical center at Kansas City Airport in Missouri, expanding access to occupational medicine for employers in a key business and transportation hub. See our latest analysis for Concentra Group Holdings Parent. Concentra Group Holdings Parent's recent Kansas City Airport expansion comes as the stock trades at $31.61, with a 30 day share price return of 4.74% and a strong year to date share price return of 62.85%. The 1...

The quarterly results for West Bancorporation, Inc. ( NASDAQ:WTBA ) were released last week, making it a good time to...

Marqeta (MQ) is drawing attention after recent share price moves, with the stock closing at US$17.07 and showing mixed returns over the past week, month, past 3 months, and year for investors tracking its performance. See our latest analysis for Marqeta. At US$17.07, Marqeta’s recent 1-day share price return of 2.03% comes against a year-to-date share price return that is down 8.03%, while the 1-year total shareholder return has declined 26.30%. This points to short-term momentum within a...

The Denver Post recently launched an investigation into resident care at Colorado’s three largest nursing home chains, including PACS Group, focusing on daily activities and wound treatment at its 19 state facilities. This scrutiny highlights how care quality and regulatory attention can influence perceptions of PACS Group’s operating practices across its broader skilled nursing network. We’ll now examine how this media investigation into resident care standards could affect PACS Group’s...

Emerson Electric (EMR) is in focus after launching new refinery software aimed at automating crude scheduling and product blending, key processes that affect margins, operational efficiency, and responsiveness to shifting refinery conditions. See our latest analysis for Emerson Electric. Emerson Electric’s latest refinery software launch comes after a period of steady share price momentum, with a 7 day share price return of 6.02% and an 8.92% year to date share price return. The 3 year total...

UGI (UGI) has drawn investor attention after recent share price moves, with the stock last closing at $37.33. With mixed short term returns, many investors are reassessing the utility-focused energy group. See our latest analysis for UGI. Recent share price gains over the past month, alongside a relatively modest year to date share price decline of 0.8%, contrast with UGI's 8.0% one year and 63.6% three year total shareholder returns. This suggests sentiment has improved after a softer patch...

EPR Properties recently entered into a Fifth Amended, Restated and Consolidated Credit Agreement, securing a US$1.0 billion senior unsecured revolving credit facility and a US$600.0 million delayed draw term loan facility, while extending maturities, lowering interest costs, and adjusting covenant calculations. An interesting aspect of this agreement is the US$1.0 billion accordion feature and the inclusion of expected forward-equity cash proceeds in asset value tests, which together can...

HCA Healthcare (HCA) has put up another solid quarter, with Q2 2026 revenue of US$20.2 billion and basic EPS of US$7.62, supported by trailing 12 month revenue of US$78.0 billion and EPS of US$30.27 alongside earnings growth of 14.6% year over year. Over recent periods the company has seen revenue move from US$18.6 billion in Q2 2025 to US$20.2 billion in Q2 2026, while quarterly EPS has stepped from US$6.91 to US$7.62 as trailing net profit margin reached 8.8% versus 8.2% a year earlier...

Millicom International Cellular (TIGO) has recently drawn investor attention after a period of mixed share performance, with the stock down 1.8% over the past day but higher over the past month. See our latest analysis for Millicom International Cellular. At a recent share price of US$94.54, Millicom International Cellular has seen short term momentum ease, with the 1 day share price return down 1.78% and the 7 day share price return down 3.86%. However, the 90 day share price return of...